Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 8/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17153845 | 0.78 | KCNN4 (0.41) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL10880209 | 0.74 | CYP1A2 (0.41) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL1431990 | 0.74 | CYP2C9 (0.43) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL3951414 | 0.74 | KCNN4 (0.39) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL3085916 | 0.72 | ALDH1A1 (0.38) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL1537246 | 0.72 | HDAC3 (0.50) | KCNN4CYP2C19ALDH1A1TSHRALOX15 | |
| SCHEMBL28066235 | 0.72 | TSHR (0.50) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL8818475 | 0.72 | TSHR (0.50) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL3360360 | 0.72 | MAPT (0.54) | KCNN4CYP2C19ALDH1A1TSHRALOX15 | |
| SCHEMBL14910050 | 0.71 | KCNN4 (0.50) | KCNN4CYP1A2CYP2C9CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7491738-B2 | Pest control agents | MEIJI SEIKA KAISHA, LTD. (JP) | 2009-02-17 | — | — | US | disclosed |
| US-20060281780-A1 | Pest control agents | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060281780-A1 | Pest control agents | CTRL, ACHE, DDT | KCNN4 3310/4885CYP1A2 677/4885CYP2C9 595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.